RECOVER · Recovery care
DSIP Injection
Understand sleep-related peptide research.
DSIP has been studied in sleep-related research. Its name does not establish a reliable sleep benefit from an injection.
Prescription required. Provider evaluation determines eligibility.
DSIP stands for delta sleep-inducing peptide and is also called emideltide. It is not interchangeable with established insomnia treatments.
Research has explored effects in sleep-related biological settings. That does not demonstrate that this injection treats insomnia or improves restorative sleep.
The exact peptide form, concentration and administration route must be verified before directions are provided.
Sleep concerns warrant a review of sleep habits, medications, other conditions and established diagnostic or treatment options.
Know the name.
Evidence before promises.
DSIP stands for delta sleep-inducing peptide and is also called emideltide. It is not interchangeable with established insomnia treatments.
-
Know the name
DSIP is also called emideltide.
-
Assess sleep concerns
An underlying condition may need evaluation.
-
Evidence before promises
A descriptive name is not proof of benefit.
Care starts with
understanding you.
A treatment decision should take your health history, current medications and goals into account. Your evaluation is the place to discuss questions, potential risks and whether another approach may be more appropriate.
-
Your health in context
Share your medical history, current medications and treatment goals.
-
A considered decision
Discuss the evidence, potential risks and available alternatives.
-
Clear next steps
If treatment is prescribed, follow the instructions for your exact medication and ask how follow-up will work.
Explore your options
with context.
Different treatments have different uses, risks and levels of evidence. Explore this care category, then discuss the options that may fit your clinical needs.
Explore recovery care-
DSIP/BPC/CJC Injection
DSIP plus BPC and CJC forms that must be identified.
The supplied name abbreviates two components. DSIP is emideltide; the exact BPC and CJC substances are not yet specified in this catalog.
Learn more -
GHK-Cu
GHK-Cu is a peptide complex involving copper.
GHK-Cu consists of a peptide associated with copper. A topical preparation and an injectable preparation are different products.
Learn more -
BPC-157 Injection
Route and ingredient identity must be clear.
BPC-157 is a synthetic peptide. The proposed injectable formulation requires its own assessment of identity, evidence and quality.
Learn more
A plan begins with
an evaluation.
Completing an assessment does not guarantee a prescription.
-
Share your history
Provide information about your health, medications and goals.
-
Review the options
A licensed provider evaluates whether treatment is clinically appropriate. Further information, testing or another type of care may be needed.
-
Understand your prescription
If prescribed, review the medication, administration directions, risks and follow-up plan before starting.
-
Revisit the plan
Discuss your response and any concerns with your prescriber. Do not change a dose or combine treatments on your own.
Know the important
information.
Every medication has potential risks. Review the complete safety information for the exact product and tell your provider about your medical conditions, allergies, pregnancy or pregnancy plans, and all medicines and supplements you take.
Compounded medications are not FDA-approved. FDA does not evaluate these preparations for safety, effectiveness or quality before marketing.
Human safety data may be incomplete. Ingredient identity, purity, formulation and administration route matter; an ingredient’s research history does not establish the safety of a blend.
Seek emergency care for trouble breathing or swelling of the face, lips or throat. Contact a clinician promptly for severe or concerning symptoms. Do not rely on routine online messaging for an emergency.
Frequently asked questions
No. That outcome is not established for this proposed preparation.
DSIP is not an FDA-approved insomnia treatment.
Do not combine substances without a clinician’s review of the exact products and interactions.
A licensed provider considers your health history, current medications, clinical needs and the evidence for the specific treatment. Further testing or a different type of care may be recommended.
No. A prescription is provided only when the evaluating provider determines that treatment is medically appropriate and available.
Follow your prescriber and pharmacy's instructions for the exact product. Ask before changing a dose, switching formulations or combining treatments.
Your next step starts with your
health.
Share your history and goals so a licensed provider can evaluate which care options may be appropriate for you.
Prescription required. Treatment is not appropriate for everyone. Assessment does not guarantee a prescription.